Dareway(SH:688579)2024-04-12 16:00Financial Performance - The company's operating revenue for the first half of 2022 decreased by 43.19 million RMB, a decline of 31.08% year-on-year, primarily due to the severe impact of COVID-19 on project execution and delivery progress [21]. - The net profit attributable to shareholders of the listed company decreased by 21.50 million RMB, a decline of 248.78% year-on-year, mainly due to the significant drop in operating revenue caused by the pandemic [22]. - The basic earnings per share for the first half of 2022 was -0.0321 RMB, compared to 0.0216 RMB in the same period last year, representing a decrease of 248.61% [21]. - The company reported a net cash flow from operating activities of -40.42 million RMB, a decrease compared to the same period last year, primarily due to delayed project delivery and reduced customer payments [22]. - The company's operating revenue for the first half of the year was ¥95,784,009.45, a decrease of 31.08% compared to ¥138,980,715.12 in the same period last year [23]. - The net profit attributable to shareholders was a loss of ¥12,859,599.76, a decline of 248.78% from a profit of ¥8,643,274.23 in the previous year [23]. - The net cash flow from operating activities was negative at ¥93,826,457.97, compared to a negative cash flow of ¥53,405,178.10 in the same period last year [23]. - The company's total assets decreased by 7.86% to ¥1,585,892,904.63 from ¥1,721,172,342.90 at the end of the previous year [23]. - The net assets attributable to shareholders decreased by 3.95% to ¥1,222,873,439.22 from ¥1,273,136,872.31 at the end of the previous year [23]. Research and Development - Research and development expenses accounted for 63.52% of operating revenue, an increase of 22.08 percentage points compared to the same period last year [21]. - The total R&D investment reached approximately CNY 60.85 million, a 5.66% increase from the previous year, with R&D expenses accounting for 63.52% of revenue [60]. - The company has filed 35 patents related to blockchain technology, with 11 granted and 24 software copyrights approved, showcasing its strong R&D capabilities [48]. - The company has developed a low-code development platform that improves software development efficiency by 30% in sectors like social security and healthcare [53]. - The company is actively developing a medical text structuring platform and a medical knowledge graph to enhance healthcare product capabilities and support intelligent medical applications [55][56]. - The company has established 8 provincial-level or above innovation platforms, including a national engineering laboratory for e-commerce transaction technology [86]. Market Presence and Contracts - The company had a total of nearly 200 million RMB in new contracts signed during the reporting period, with a backlog of orders amounting to 480 million RMB, both showing growth compared to the previous year [21]. - The company has established a strong presence in the smart social security sector, covering over 100 cities and holding a leading market share nationally [27]. - The company has expanded its market presence outside Shandong, covering provinces such as Jiangsu, Anhui, and Zhejiang, and has established a growing business center in the Yangtze River Delta region [93]. - The company’s main business revenue from Shandong Province was 60.2499 million yuan, accounting for 63.42% of total main business revenue, indicating a high concentration risk [96]. Technology and Innovation - The company has developed a proprietary blockchain technology system, "Daiwei Chain," but faces risks related to market acceptance and long-term planning [100]. - The company is focusing on blockchain technology applications in areas like inclusive finance and has already secured business orders in these sectors [93]. - The company has successfully implemented a new generation of electricity information collection systems and innovative products in key regions such as Shandong, Chongqing, and Shaanxi [36]. - The company has developed a customer-side energy internet smart platform, achieving the first domestic distributed photovoltaic peak shaving work [36]. - The company aims to promote the application of blockchain technology in public finance and healthcare sectors, enhancing data security and operational efficiency [63]. Corporate Governance and Compliance - The company did not propose any profit distribution plan or capital reserve transfer to increase share capital during the reporting period [6]. - There were no non-operating fund occupation situations by controlling shareholders or related parties [7]. - The report period was not audited, and the management team confirmed the accuracy and completeness of the financial report [4]. - The company has undergone significant management changes, including the election of a new chairman and several core technical personnel [116]. - The company guarantees that its IPO documents do not contain false records or misleading statements, taking legal responsibility for their accuracy [131]. Future Outlook and Strategy - The company plans to continue focusing on R&D and market expansion despite the current financial challenges, aiming for recovery in future quarters [175]. - The company aims to improve fund operation efficiency and reduce operational costs by accelerating technology research and market promotion [129]. - The company is committed to supporting the digital economy and achieving carbon neutrality goals through innovative energy management applications [68]. - The company is focusing on integrating blockchain with privacy computing to enhance data security in insurance and financial services [76].